On the public citation graph
Dasatinib-induced acute hepatitis
0 signed · 39 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/ajh.20486openalex-snapshot
Imatinib mesylate as a cause of acute liver failure
inferredcites →https://doi.org/10.1016/0895-4356(93)90101-6openalex-snapshot
Causality assessment of adverse reactions to drugs—I. A novel method based on the conclusions of international consensus meetings: Application to drug-induced liver injuries
inferredcites →https://doi.org/10.1016/s0399-8320(04)95160-3openalex-snapshot
Hépatite aiguë cytolytique induite par l’imatinib mesylate
inferredcites →https://doi.org/10.1038/sj.leu.2402702openalex-snapshot
Imatinib mesylate-induced hepato-toxicity in chronic myeloid leukemia demonstrated focal necrosis resembling acute viral hepatitis
inferredcites →https://doi.org/10.1038/sj.leu.2402910openalex-snapshot
Histological features of acute hepatitis after imatinib mesylate treatment
inferredcites →https://doi.org/10.1080/10245330600937929openalex-snapshot
Imatinib-induced immune hepatitis: Case report and literature review
inferredcites →https://doi.org/10.1097/01.meg.0000216941.42306.0eopenalex-snapshot
Imatinib mesylate-induced acute hepatitis in a patient treated for gastrointestinal stromal tumour
inferredcites →https://doi.org/10.1097/01.meg.0000243867.56454.13openalex-snapshot
Imatinib mesylate-induced acute hepatitis with autoimmune features
inferredcites →https://doi.org/10.1182/blood-2003-07-2323openalex-snapshot
Fatal hepatic necrosis following imatinib mesylate therapy
inferredcites →https://doi.org/10.1532/ijh97.05034openalex-snapshot
Severe Hepatic Injury Caused by Imatinib Mesylate Administered for the Treatment of Chronic Myeloid Leukemia and the Efficacy of Prednisolone for its Management
inferredcites →https://doi.org/10.3748/wjg.v13.i48.6608openalex-snapshot
Imatinib-induced fatal acute liver failure
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.3777190openalex-extracted
Relative Risk of Hepatotoxicity Associated With BCR-ABL Tyrosine Kinase Inhibitors in the Treatment of Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2021.20165openalex-snapshot
Comparison of Hepatotoxicity Associated With New BCR-ABL Tyrosine Kinase Inhibitors vs Imatinib Among Patients With Chronic Myeloid Leukemia
inferred← citeshttps://doi.org/10.1002/pds.1645openalex-snapshot
Current awareness: Pharmacoepidemiology and drug safety
inferred← citeshttps://doi.org/10.1007/s11901-017-0381-7openalex-snapshot
Hepatotoxicity of New Antitumor Agents
inferred← citeshttps://doi.org/10.1007/s13318-024-00881-9openalex-snapshot
Pharmacokinetics of Dasatinib in Rats: a Potential Food–Drug Interaction with Naringenin
inferred← citeshttps://doi.org/10.1016/j.clinre.2022.102004openalex-snapshot
Acute fulminant hepatitis related to the use of dasatinib: First case report
inferred← citeshttps://doi.org/10.1016/j.critrevonc.2020.103127openalex-snapshot
Multikinase inhibitor-induced liver injury in patients with cancer: A review for clinicians
inferred← citeshttps://doi.org/10.1016/j.jprot.2011.05.035openalex-snapshot
Dasatinib, imatinib and staurosporine capture compounds — Complementary tools for the profiling of kinases by Capture Compound Mass Spectrometry (CCMS)
inferred← citeshttps://doi.org/10.1016/j.jsps.2023.101819openalex-snapshot
Herb-drug interaction: Effect of sinapic acid on the pharmacokinetics of dasatinib in rats
inferred← citeshttps://doi.org/10.1016/j.taap.2012.04.010openalex-snapshot
Oxidative stress is involved in Dasatinib-induced apoptosis in rat primary hepatocytes
inferred← citeshttps://doi.org/10.1016/j.tranon.2015.12.004openalex-snapshot
Dasatinib-Induced CMV Hepatitis in an Immunocompetent Patient: A Rare Complication of a Common Drug
inferred← citeshttps://doi.org/10.1021/tx200304ropenalex-snapshot
2,7-Disubstituted-Pyrrolotriazine Kinase Inhibitors with an Unusually High Degree of Reactive Metabolite Formation
inferred← citeshttps://doi.org/10.1080/13543784.2023.2179481openalex-snapshot
Pharmacokinetics and safety of dasatinib and its generic: a phase I bioequivalence study in healthy Chinese subjects
inferred← citeshttps://doi.org/10.1080/17425255.2020.1815705openalex-snapshot
Potential role of drug metabolizing enzymes in chemotherapy-induced gastrointestinal toxicity and hepatotoxicity
inferred← citeshttps://doi.org/10.1111/bph.12047openalex-snapshot
Metabolism and bioactivation of famitinib, a novel inhibitor of receptor tyrosine kinase, in cancer patients
inferred← citeshttps://doi.org/10.1124/dmd.108.025932openalex-snapshot
Characterization of Dasatinib and Its Structural Analogs as CYP3A4 Mechanism-Based Inactivators and the Proposed Bioactivation Pathways
inferred← citeshttps://doi.org/10.1177/09603271231188492openalex-snapshot
Hydroxychloroquine ameliorates dasatinib-induced liver injury via decrease in hepatic lymphocytes infiltration
inferred← citeshttps://doi.org/10.1186/s13321-019-0402-3openalex-snapshot
Learning important features from multi-view data to predict drug side effects
inferred← citeshttps://doi.org/10.1517/17425255.2010.506873openalex-snapshot
Metabolism considerations for kinase inhibitors in cancer treatment
inferred← citeshttps://doi.org/10.18632/oncotarget.3357openalex-snapshot
Autophagy protects against dasatinib-induced hepatotoxicity via p38 signaling
inferred← citeshttps://doi.org/10.2217/pgs.13.24openalex-snapshot
Genetic Characterization to Improve Interpretation and Clinical Management of Hepatotoxicity Caused by Tyrosine Kinase Inhibitors
inferred← citeshttps://doi.org/10.3109/10428194.2012.695779openalex-snapshot
Off-target effects of BCR–ABL1 inhibitors and their potential long-term implications in patients with chronic myeloid leukemia
inferred← citeshttps://doi.org/10.3310/hta16220openalex-snapshot
Dasatinib and nilotinib for imatinib-resistant or -intolerant chronic myeloid leukaemia: a systematic review and economic evaluation.
inferred← citeshttps://doi.org/10.3389/fonc.2023.1113462openalex-snapshot
Adverse reactions after treatment with dasatinib in chronic myeloid leukemia: Characteristics, potential mechanisms, and clinical management strategies
inferred← citeshttps://doi.org/10.3390/molecules28041602openalex-snapshot
Effects of Apigenin on Pharmacokinetics of Dasatinib and Probable Interaction Mechanism
inferred← citeshttps://doi.org/10.5045/br.2021.2021117openalex-snapshot
A narrative review on adverse effects of dasatinib with a focus on pharmacotherapy of dasatinib-induced pulmonary toxicities
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.